VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCv replicon cells.

Antimicrobial Agents and Chemotherapy
Kai LinChao Lin

Abstract

The NS3-4A serine protease of hepatitis C virus (HCV) is essential for viral replication and therefore has been one of the most attractive targets for developing specific antiviral agents against HCV. VX-950, a highly selective, reversible, and potent peptidomimetic inhibitor of the HCV NS3-4A protease, is currently in clinical development for the treatment of hepatitis C. In this report, we describe the in vitro characterization of anti-HCV activities of VX-950 in subgenomic HCV replicon cells. Incubation with VX-950 resulted in a time- and dose-dependent reduction of HCV RNA and proteins in replicon cells. Moreover, following a 2-week incubation with VX-950, a reduction in HCV RNA levels of 4.7 log(10) was observed, and this reduction resulted in elimination of HCV RNA from replicon cells, since there was no rebound in replicon RNA after withdrawal of the inhibitor. The combination of VX-950 and alpha interferon was additive to moderately synergistic in reducing HCV RNA in replicon cells with no significant increase in cytotoxicity. The benefit of the combination was sustained over time: a 4-log(10) reduction in HCV RNA level was achieved following a 9-day incubation with VX-950 and alpha interferon at lower concentrations th...Continue Reading

References

Oct 1, 1990·Antiviral Research·M N Prichard, C Shipman
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M HijikataK Shimotohno
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·C Lin, C M Rice
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·UNKNOWN National Institutes of Health
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·John G McHutchison, Keyur Patel
Apr 15, 2003·Clinics in Liver Disease·Leonard B Seeff, Jay H Hoofnagle
Oct 31, 2003·AIDS Research and Human Retroviruses·Marta BoffitoVeronica Miller
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Doris B StraderUNKNOWN American Association for the Study of Liver Diseases
May 25, 2004·Antimicrobial Agents and Chemotherapy·Liangjun LuAkhteruzzaman Molla
Aug 28, 2004·Organic Letters·Anne-Marie FaucherMontse Llinàs-Brunet
Sep 3, 2004·Bioorganic & Medicinal Chemistry Letters·Yvonne YipShu-Hui Chen
Feb 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kui LiStanley M Lemon
Feb 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eileen FoyMichael Gale
Feb 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Markus ReiserGerhard G Steinmann
Jun 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jin ZhongFrancis V Chisari
Jun 11, 2005·Science·Brett D LindenbachCharles M Rice

❮ Previous
Next ❯

Citations

Sep 29, 2011·Virus Genes·Najam us Sahar Sadaf ZaidiIshtiaq Qadri
May 29, 2012·Bulletin of Mathematical Biology·Libin RongAlan S Perelson
Mar 6, 2007·Current Gastroenterology Reports·Mark S Sulkowski
Jul 24, 2010·Advances in Therapy·Andrew J Fowell, Kathryn L Nash
Apr 5, 2013·Clinical Pharmacokinetics·Tony K L KiangMary H H Ensom
Feb 2, 2010·Nature Biotechnology·Christopher T JonesCharles M Rice
Dec 1, 2007·Nature Reviews. Drug Discovery·Erik De Clercq
May 1, 2009·The New England Journal of Medicine·Jay H Hoofnagle
Jun 24, 2011·The New England Journal of Medicine·Stefan ZeuzemUNKNOWN REALIZE Study Team
Jan 7, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vincent SorianoStefan Zeuzem
Apr 12, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James C SullivanTara L Kieffer
Jun 10, 2011·The Journal of Antimicrobial Chemotherapy·Vincent SorianoPablo Barreiro
May 7, 2010·Science Translational Medicine·Libin RongAlan S Perelson
Mar 21, 2012·Antimicrobial Agents and Chemotherapy·Angela M LamPhillip A Furman
Oct 17, 2007·Antimicrobial Agents and Chemotherapy·Yi ZhouChao Lin
Nov 28, 2007·Antimicrobial Agents and Chemotherapy·Agnieszka GozdekAnna M Boguszewska-Chachulska
Jan 28, 2009·Antimicrobial Agents and Chemotherapy·Tse-I LinKenneth Simmen
Mar 12, 2008·Antimicrobial Agents and Chemotherapy·David L WylesRobert T Schooley
Dec 21, 2012·Antimicrobial Agents and Chemotherapy·Wei-Chun ChenJin-Ching Lee
Apr 17, 2009·Journal of Virology·Harel DahariSusan L Uprichard
Jan 27, 2012·Journal of Virology·Mohammed A SarhanTomasz I Michalak
Nov 19, 2013·Virologica Sinica·Matthew BrecherHongmin Li
May 17, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Concetta PanebiancoValerio Pazienza
Dec 15, 2010·Expert Review of Anti-infective Therapy·Tabinda Burney, Geoffrey Dusheiko
Sep 13, 2011·Expert Review of Anti-infective Therapy·Maria Ripoli, Valerio Pazienza
Feb 16, 2012·Expert Opinion on Pharmacotherapy·Nicole Forestier, Stefan Zeuzem
Oct 13, 2007·Expert Opinion on Pharmacotherapy·Rohit Satoskar, Donald M Jensen
Aug 10, 2007·Expert Opinion on Investigational Drugs·Julie SheldonVincent Soriano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.